glp-1 obesity drug news today oct 23 2025 Use of diabetes and anti-obesity drugs surges nationwide CVS obesity drug deal puts

For instance, in chimeric human cerebral organoids (chCOs), astrocytes and neurons carrying the APOE4 genotype could jointly promote tau phosphorylation in neurons, closely linked to the role of APOE4 in increasing cholesterol levels and lipid droplet content, suggesting that APOE4 may affect tau phosphorylation in AD by influencing lipid metabolism

At 2.4 mg weekly, average weight loss reached about 15% over 68 weeks. Response varied widely: 86% lost at least 5%, 69% lost 10%, half lost 15%, and about one-third lost 20%. These results describe that cohort rather than a universal forecast

If this sounds overwhelming, don't worry

Learn about how our DVMs think about cat aging Dr

I., Begum, K., Hussain, A., Iqbal, J., Aufreiter, S., Beggs, M